Collectively, these data indicated that TUG1/miR-382/EZH2 ceRNA regulatory signaling pathway enhanced PC cell migration capacity and EMT formation and might be a potential novel therapeutic target for PC (139). The gene discussed is TUG1; the disease is pachyonychia congenita.